Anastasis Biotec (AB) is a company that is developing a human protein-based product, Syntana-4 (S-4), that inhibits Cancer Stem Cells (CSC) - the growth engine of cancer. The global cancer drug market was at ~$200 billion in 2019. S-4 will initially target use for patients with relapsed prostate cancer which caused 3.8% of global cancer deaths in 2018. The company asserts that S-4 will have low manufacturing costs, making it affordable, enabling ‘mass-market’ sales. AB has raised £450,000 in equity convertible loans and grants in 2019 & 2020, including an Innovate-UK award. It is also aiming to progress S-4 further in collaboration with the University of Chicago’s cancer stem cell therapeutics Research and development (R&D) program. The company will use the investment to complete lab-testing before starting clinical trials.
days to go:
Expired
investment:
£270,543
planarTECH is an engineering company founded in 2014 as a provider of process equipment for the growth and characterisation of graphene and other emerging 2D materials. Its core product line is the planarGROW Chemical Vapor (CVD) system. The company has the ability to deliver scalable production systems that allow lower-cost production of graphene in comparison to other options currently available in the market. Moreover, from 2014 to 2019, the company’s cumulative revenues exceeded £5 million. The company's products have been installed and used by faculties and students at prestigious universities like Stanford University (USA), IIT- Bombay (India), Deakin University (Australia), and many others. From the investment, the company will utilise 45% as working capital, 30% in Capital Expenditures (CAPEX), 15% in R&D and 10% in hiring additional staff.
days to go:
Expired
investment:
£425,061
Nayanacare is a mobile and pc app that allows individual customers to make the right choice of care services and carers quick and easy. Care suppliers can reduce costs by using Nayanacare as a dedicated marketing platform and take advantage of the platforms business management capabilities.
days to go:
Expired
investment:
£76,030
Aerobit is a smart inhaler, a tool for tracking medication use that records each time inhalers are taken and comes in a variety of cool toy designs. Built in sensors can even tell if the inhaler has been shaken correctly.
days to go:
Expired
investment:
£116,960
gowithYamo aims to make art more accessible to everyone, from art newbies to experienced gallery-goers through its application. Users can collect Yamo points by checking-in to galleries and exchanging them for rewards such as art prints and exhibition tickets from the company's in-app store. gowithYamo provides support to galleries, museums and artists by exposing them to an active community of art lovers. The company also offers custom-built virtual exhibition spaces where artists can show and sell their work to a sizeable digital audience. gowithYamo has collaborated with art entities like Roy's Art Fair, The Other Art Fair, Harlesden High Street, and many others. It has a social media presence of 50,000+ followers. The company will use 30% of the investment to expand across different demographics, 25% to further finetune its virtual exhibition platform, 20% for marketing, and 25% to implement Artificial Intelligence (AI) in the gowithYamo app to help recommend exhibitions to its users.
days to go:
Expired
investment:
£161,105
Rightangled are a CQC registered healthcare provider specialising in genetic testing and is backed by the NHS England. They have designed and filed a patent for their Cardiac genetic test and are now seeking to expand their testing and telemedicine service into new markets and new tests.
days to go:
Expired
investment:
£433,290
Plumen are aiming to persuade people to use energy efficient lighting by creating beautiful bulbs. To date, Plumen have expanded the business and funded R&D using their own sales. However now they are looking to expand. Plumen are seeking investment to: launch new product ranges, support and grow sales into new markets and develop smart lighting for launch in 2017.
days to go:
Expired
investment:
£695,680
Go Modular design and build off-site modules for the construction industry. Using their innovative modular construction technology they aim to revolutionise the construction process making it more time efficient and less expensive to produce buildings. In 2018, Go Modular are looking to open their first factory in the UK which will enable them to offer the construction industry factory-produced building units that form the finished structure at the construction site.
days to go:
Expired
investment:
£412,420
Koor aims at helping singers become more musical and confident. Founded by an experienced conductor and software engineer, Koor aims to support choirs in extending the complexity and range of their repertoire. It has already released the Beta version of the app. The company has three revenue streams: advertising and sponsorship by music publishers, general advertising, and subscription payments. With the proceeds, the company will set up its first recording unit. Furthermore, it will enhance workforce, record content for the app, and purchase recording equipment and install it.
days to go:
Expired
investment:
£123,117
Pass the Keys is a leading short-let tech platform operating in 20 cities across the UK. Till date, the company has hosted 30,000+ guests and earned £15 million for its hosts. The company lists a landlord's property on appropriate portals, finds relevant guests for an event or function, looks after their needs, and even takes care of cleaning up the venue after an event. The company's end-to-end technology automates the majority of the tasks such as job scheduling, invoicing, calendar syncing, and pricing with reliable support staff ready to assist with any eventuality. The company has achieved good ratings on Google reviews, Trustpilot and Glassdoor. The company will use 50% of the investment to expand its franchise, 30% for product development, and 20% for training personnel and supporting infrastructure.
days to go:
Expired
investment:
£1,069,632
